NEW YORK, Dec. 28, 2015 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets, today announced Hemostemix Inc. (TSX-V: HEM; OTCQX: HMTXF), a clinical-stage biotechnology company, has qualified to trade on the OTCQX® Best Market.
Hemostemix begins trading today on OTCQX under the symbol "HMTXF." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
"We are proud to welcome Hemostemix to the OTCQX market," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "OTCQX companies are distinguished for their high-quality financial and operating standards and commitment to providing a transparent and efficient trading market for their investors. We look forward to helping Hemostemix expand its visibility in the U.S. investment market."
Roth Capital Partners, LLC serves as Hemostemix's Principal American Liaison ("PAL") on OTCQX, responsible for providing professional guidance on OTCQX requirements.
Hemostemix is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. ACP-01, Hemostemix's lead clinical stage candidate, is an autologous cell therapy for the treatment critical limb ischemia. ACP-01 is currently in a Phase 2 clinical trial in Canada, South Africa and the United States.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial markets for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into markets to inform investors of opportunities and risks: the OTCQX® Best Market; the OTCQB® Venture Market; and the OTC Pink® Open Market. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial markets, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, email@example.com
SOURCE OTC Markets Group Inc.